InvestorsHub Logo
Followers 41
Posts 33714
Boards Moderated 0
Alias Born 07/08/2003

Re: None

Monday, 03/17/2014 7:35:23 AM

Monday, March 17, 2014 7:35:23 AM

Post# of 7747
CytRx Establishes Research and Development Team and Opens New Laboratory to Develop Albumin-Binding Anti-Cancer Drug Platform
http://finance.yahoo.com/news/cytrx-establishes-research-development-team-110000252.html

OK...now we're "talking"!!!!!! Good development.

The new laboratory, located in Freiburg, Germany, will conduct discovery and translational research to create drug candidates that utilize novel linker technologies that couple chemotherapeutic agents and proteins either inside the body or externally, and then concentrate drug in tumors. The work done at the laboratory will generate new pipeline product candidates and thereby enable expansion of the Company’s existing patent portfolio, adding to intellectual property that was originally developed by the KTB Tumor Biology Center in Freiburg and licensed exclusively to CytRx.



Looks like the partnership is moving forward...Great development!